BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 986262)

  • 1. Inhibition of antibody-dependent cell-mediated cytotoxicity (ADCC) as a means of detection of immune complexes in the sera of patients with thyroid disorders and bronchogenic carcinoma.
    Barkas T; AL-Khateeb SF; Irvine WJ; Davidson NM; Roscoe P
    Clin Exp Immunol; 1976 Aug; 25(2):270-9. PubMed ID: 986262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of antibody-dependent cellular cytotoxicity by artificial immune complexes and pathological sera.
    Howat JM; Moore M; Hilton AM; Kimber I
    Immunology; 1979 Jun; 37(2):467-75. PubMed ID: 468310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum factors influencing antibody-directed cell-mediated cytotoxicity (ADCC) and their effects on the detection of immune complexes by inhibition of ADCC.
    Barkas T; Al-Khateeb SF
    Immunology; 1979 Feb; 36(2):299-306. PubMed ID: 108202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C1q binding activity in the sera of patients with chronic lung diseases.
    Cooper KM; Moore M; Hilton AM
    Clin Exp Immunol; 1981 Jul; 45(1):18-28. PubMed ID: 6975678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reactivity of low molecular weight material in cellular immune complex assays.
    Cooper KM; Moore M
    Clin Exp Immunol; 1983 May; 52(2):407-16. PubMed ID: 6602679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Demonstration of antibodies against tumor-associated antigens in the serum patients with bronchogenic carcinoma using anticomplement immunofluorescence on xenotransplants of human tumors].
    Stiller-Winkler R; Stark M; Idel H
    Zentralbl Bakteriol Mikrobiol Hyg B; 1985 Mar; 180(4):381-93. PubMed ID: 2988233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a tumor-related protein antigen in immune complexes derived from pleural effusions of patients with bronchial carcinoma.
    Lawniczak M; Jezewska E; Górny MK; Zeromski J
    Neoplasma; 1985; 32(1):9-20. PubMed ID: 3982564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneity of circulating immune complexes in chronic lung diseases.
    Cooper KM; Moore M
    J Clin Lab Immunol; 1982 Apr; 7(3):155-61. PubMed ID: 6980284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-tubulin antibodies in autoimmune thyroid disorders.
    Rousset B; Bernier-Valentin F; Poncet C; Orgiazzi J; Madec AM; Monier JC; Mornex R
    Clin Exp Immunol; 1983 May; 52(2):325-32. PubMed ID: 6688044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The fluctuation of circulating immune complexes level in patients with malignancy.
    Vodvárka P; Vodvárka T; Foukalová J
    Neoplasma; 1984; 31(4):485-9. PubMed ID: 6472521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of immune complexes and immunoglobulin G antibodies reactive with neutrophils in the sera of patients with Felty's syndrome.
    Starkebaum G; Arend WP; Nardella FA; Gavin SE
    J Lab Clin Med; 1980 Aug; 96(2):238-51. PubMed ID: 6772719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carcinoembryonic antigen in bronchogenic carcinoma.
    Zatloukal P; Voslárová Z; Mĕricka O; Svarcová H; Schützner J
    Neoplasma; 1987; 34(1):73-6. PubMed ID: 3561607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antibodies against tumor associated antigens of human bronchogenic carcinoma: demonstration by anti-complement immunofluorescence (author's transl)].
    Schlipköter HW; Stiller-Winkler R; Idel H; Knopp J
    Zentralbl Bakteriol Mikrobiol Hyg B; 1981; 174(1-2):105-14. PubMed ID: 7034407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of B cell cytotoxicity by aggregated IgG and immune complexes.
    d'Apice AJ; Tait BD; Lambert G
    Tissue Antigens; 1977 Nov; 10(5):273-8. PubMed ID: 305139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody specific for lung cancer cells detected in sera of patients with bronchogenic carcinoma.
    Yasumoto K; Manabe H; Nomoto K; Inokuchi K
    Gan; 1983 Aug; 74(4):595-601. PubMed ID: 6628908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Circulating immune complexes and bronchopulmonary cancers].
    Pourrat JP; Leophonte P; Pourrat E; Mouysset B; Conte JJ; Delaude A
    Rev Mal Respir; 1984; 1(1):31-6. PubMed ID: 6611568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Determination of secretory immunoglobulin A, IgG and IgM in bronchial lavage from patients with primary and metastatic lung neoplasms ].
    Viramontes L; Cicero R; Acosta G; Barragan L; Orozco R; Torres S
    Arch Invest Med (Mex); 1989; 20(2):175-81. PubMed ID: 2604502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Killer cells and immune complexes in thyroid disease.
    Calder EA; Penhale WJ; Irvine WJ
    Proc R Soc Med; 1975 Apr; 68(4):250-2. PubMed ID: 1242808
    [No Abstract]   [Full Text] [Related]  

  • 19. [Autoimmunity in patients with bronchogenic carcinomas: occurrence of antibodies against nuclear antigens, chromosomes and ds-deoxyribonucleic acid].
    Dellen H; Seemayer NH
    Zentralbl Bakteriol Mikrobiol Hyg B; 1983 Sep; 177(6):451-68. PubMed ID: 6322478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Raji cell assay for immune complexes. Evidence for detection of Raji-directed immunoglobulin G antibody in sera from patients with systemic lupus erythematosus.
    Anderson CL; Stillman WS
    J Clin Invest; 1980 Aug; 66(2):353-60. PubMed ID: 6995484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.